ACCP has developed a Public Policy Initiative to ensure that its views are presented to the public and governmental leaders. This effort will be in concert with other organizations that are already working together to articulate a common viewpoint. A primary goal of the initiative will be to explain the importance of clinical pharmacology in the effort to encourage the optimal use of therapeutics to improve healthcare for all.
ACCP will issue Policy Statements or provide professional opinions on topics concerning and relevant to clinical pharmacology, and seek to represent the views of the College on these topics through the following efforts:
- Work with US Congress and key congressional committees to support annual funding for the Food and Drug Administration, National Institutes of Health and the Agency for Healthcare Research and Quality.
- Support additional funding for clinical pharmacology with a focus on the translation of biomedical and clinical research into healthcare and health, including comparative effectiveness research, by the Agency for Healthcare Research and Quality and the National Institutes of Health and other Federal agencies as appropriate.
- Collaborate with other scientific and educational organizations to develop position statements on legislation impacting clinical pharmacology, drug development, the Food and Drug Administration and National Institutes of Health, and articulate those positions to key legislators.
- Seek opportunities to support clinical pharmacology issues and programs outside the US to further the science of the discipline, enhance the efficiency of drug development, and encourage te optimal use of therapeutics to improve healthcare for all.
Archived Policy Statements